Highly stable, ligand-clustered "patchy" micelle nanocarriers for systemic tumor targeting

被引:66
作者
Poon, Zhiyong [1 ]
Lee, Jung Ah [1 ]
Huang, Shenwen [1 ]
Prevost, Richard J. [1 ]
Hammond, Paula T. [1 ]
机构
[1] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
关键词
Targeted drug delivery; Folate; Nanoparticles; FOLATE RECEPTOR; IN-VIVO; POLYMERIC MICELLES; CREMOPHOR-FREE; DRUG-DELIVERY; GENEXOL-PM; PHASE-I; PACLITAXEL; NANOPARTICLES; THERAPEUTICS;
D O I
10.1016/j.nano.2010.07.008
中图分类号
TB3 [工程材料学];
学科分类号
082905 [生物质能源与材料];
摘要
A novel linear-dendritic block copolymer has been synthesized and evaluated for targeted delivery. The use of the dendron as the micellar exterior block in this architecture allows the presentation of a relatively small quantity of ligands in clusters for enhanced targeting, thus maintaining a long circulation time of these "patchy" micelles. The polypeptide linear hydrophobic block drives formation of micelles that carry core-loaded drugs, and their unique design gives them extremely high stability in vivo. We have found that these systems lead to extended time periods of increased accumulation in the tumor (up to 5 days) compared with nontargeted vehicles. We also demonstrate a fourfold increase in efficacy of paclitaxel when delivered in the targeted nanoparticle systems, while significantly decreasing in vivo toxicity of the chemotherapy treatment. From the Clinical Editor: A micellar vehicle using dendrons as the exterior block in combination with a polypeptide hydrophobic block was shown to incorporate and deliver paclitaxel to xenograft tumors with a four-fold increase in efficacy and reduced toxicity. Published by Elsevier Inc.
引用
收藏
页码:201 / 209
页数:9
相关论文
共 46 条
[1]
Factors affecting the clearance and biodistribution of polymeric nanoparticles [J].
Alexis, Frank ;
Pridgen, Eric ;
Molnar, Linda K. ;
Farokhzad, Omid C. .
MOLECULAR PHARMACEUTICS, 2008, 5 (04) :505-515
[2]
Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[3]
TAXOL-LIPID INTERACTIONS - TAXOL-DEPENDENT EFFECTS ON THE PHYSICAL-PROPERTIES OF MODEL MEMBRANES [J].
BALASUBRAMANIAN, SV ;
STRAUBINGER, RM .
BIOCHEMISTRY, 1994, 33 (30) :8941-8947
[4]
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging [J].
Bartlett, Derek W. ;
Su, Helen ;
Hildebrandt, Isabel J. ;
Weber, Wolfgang A. ;
Davis, Mark E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (39) :15549-15554
[5]
Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentration [J].
Biessen, EAL ;
Noorman, F ;
vanTeijlingen, ME ;
Kuiper, J ;
BarrettBergshoeff, M ;
Bijsterbosch, MK ;
Rijken, DC ;
vanBerkel, TJC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (45) :28024-28030
[6]
Development of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel [J].
Burt, HM ;
Zhang, XC ;
Toleikis, P ;
Embree, L ;
Hunter, WL .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :161-171
[7]
Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo Forster resonance energy transfer imaging [J].
Chen, Hongtao ;
Kim, Sungwon ;
He, Wei ;
Wang, Haifeng ;
Low, Philip S. ;
Park, Kinam ;
Cheng, Ji-Xin .
LANGMUIR, 2008, 24 (10) :5213-5217
[8]
Nanoparticle therapeutics: an emerging treatment modality for cancer [J].
Davis, Mark E. ;
Chen, Zhuo ;
Shin, Dong M. .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (09) :771-782
[9]
The dawning era of polymer therapeutics [J].
Duncan, R .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :347-360
[10]
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo [J].
Farokhzad, OC ;
Cheng, JJ ;
Teply, BA ;
Sherifi, I ;
Jon, S ;
Kantoff, PW ;
Richie, JP ;
Langer, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (16) :6315-6320